top of page
BGEM Banner

Blood Glucose Evaluation & Monitoring (BGEM™)

BGEM logo

BGEM™ is the world’s first non-invasive blood glucose monitoring solution powered by an AI-driven algorithm. It is a cloud-based technology that enables wearables and hearables with Photoplethysmography (PPG) sensors to assess the risk of impaired glucose regulation.​

The Global Challenge of Diabetes¹

Why the need for BGEM™ ?

What are the benefits?

Diabetes is a global challenge as it is rising at an alarming rate around the world. It is one of the main causes of death in most developed countries, and is also the leading cause of blindness, stroke, amputation and kidney failure.

1 in 2

Adults

(>240 million people) in the world is undiagnosed

643

Mil

people will be diabetic by 2030

537

Mil

adults worldwide lived with diabetes in 2021

Diabetes incurred US$966 billion in global health expenditure in 2021

Regular monitoring of blood glucose plays an important part in managing diabetes risks. Health screenings or finger pricking with lancet are the common procedures used in determining blood glucose levels. Nonetheless, these are not regular and proactive routines that are built into a person’s daily life habits.

Actxa identifies the need for an innovative solution that offers frequent assessments and early detection to prevent the onset of Type 2 diabetes mellitus (T2DM) or to delay the progression of this killer illness.

Non-invasive

Scalability

Easy & convenient

Frequent Measurement

Cost-effective

Sensor Agnostic

How does it work?

What are the achievements?

Cutting-edge technology

Leveraging the latest technological advancement in signal processing, wearable technologies, and AI to assess the risk of impaired glucose regulation.

Photoplethysmography sensor

Using signals from consumer-grade wrist-worn photoplethysmography (PPG) sensors, the AI model computes the relevant digital biomarkers correlated with prediabetes or T2DM in order to monitor and evaluate diabetic risks.

Smart Watches & Fitness wearables

AI Model

Diabetic Risk Level

01

First company in the world to develop a comprehensive AI solution that leverages consumer-grade wearables to detect blood glucose dysregulation.

02

BGEM™ completed the clinical validation in 2022 and is in the process of submitting our paper for peer review.

03

MBR Technology Excellence Awards 2022

Won the SBR Technology Excellence Awards 2022 under the AI - Healthcare Technology Category.

04

JStyle

Partnership with Joint Chinese Limited, a leading manufacturer and solution provider for digital health wearables in China, to market and distribute wearables powered by BGEM™ worldwide.

References:

1. International Diabetes Federation. (2021). IDF Diabetes Atlas.
https://diabetesatlas.org/idfawp/resource-files/2021/07/IDF_Atlas_10th_Edition_2021.pdf

Opportunities for business.

Get in touch with us to discuss the opportunities for your business

bottom of page